Zdrowie i gospodarka · 01/04/2014

FDA Releases Guidance on Fees for Human Drug Compounding Outsourcing Facilities

The Food and Drug Administration (FDA) has announced a new guidance document outlining the fees required for human drug compounding outsourcing facilities registered under the Federal Food, Drug, and Cosmetic Act, with the aim of ensuring compliance and transparency in the industry.